Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
market cap
Pharma
Novo, Lilly lost value in Q3 while BMS, Gilead and Sanofi surged
While Eli Lilly and Novo Nordisk experienced market cap declines in Q3, BMS, Gilead and Sanofi saw their value increase, according to GlobalData.
Kevin Dunleavy
Nov 8, 2024 5:00am
Merck, Vertex and Lilly led biopharma share price gains in 2022
Feb 7, 2023 10:00am
Sanofi's setbacks do not justify its current valuation: ODDO
Aug 30, 2022 11:05am
Bayer, AbbVie showed industry’s highest market cap growth in Q1
May 19, 2022 6:56am
Moderna's sky-high market value splits Wall Street
Aug 11, 2021 12:21pm
AbbVie, Lilly lead Big Pharma's 2020 market cap growth
Feb 19, 2021 12:07pm
